Jan 9
|
Health Care Roundup: Market Talk
|
Jan 9
|
FTSE 100 LIVE: Hays shares slide after 'difficult December', GSK in $1bn respiratory drug deal
|
Jan 9
|
GSK to buy asthma treatment firm Aiolos Bio in £1.1bn deal
|
Jan 9
|
GSK strikes £1.1bn deal for asthma drugmaker
|
Jan 9
|
GSK Enters Agreement to Acquire Aiolos Bio
|
Jan 9
|
Trending tickers: Apple | Samsung | GSK | Jupiter
|
Jan 9
|
GSK Expands Respiratory Pipeline With Aiolos Bio Buy
|
Dec 24
|
15 Undervalued Defensive Stocks For 2024
|
Dec 22
|
GSK to cut US prices for Advair, Valtrex and Lamictal
|
Dec 21
|
Sunak hosts bosses for Business Council gathering
|
Dec 14
|
UPDATE 2-US CDC says there's urgent need to increase respiratory vaccine coverage
|
Dec 14
|
Moderna: Stock soars on cancer vaccine data, CEO Bancel takes on commercial role
|
Dec 14
|
Several Reasons for the Outperformance of GSK plc (GSK) in Q3
|
Dec 12
|
30 Largest Pharmaceutical Companies in the World
|
Dec 12
|
19 Countries that Encourage Immigration from USA
|
Dec 12
|
GSK Awards $1M in COiMMUNITY Initiative Grants to Support Adult Immunization and Health Equity
|
Dec 7
|
FTC warns pharma companies on excessive drug patenting
|
Dec 7
|
20 Countries with Free Health Care
|
Dec 4
|
Glaxo (GSK) Upgraded to Buy: What Does It Mean for the Stock?
|
Dec 4
|
Is GSK PLC Sponsored ADR (GSK) Stock Outpacing Its Medical Peers This Year?
|